B-cell prolymphocytic leukemia biopsy: Difference between revisions
Jump to navigation
Jump to search
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Ovierview== | ==Ovierview== | ||
B-cell prolymphocytic leukemia biopsy is considered a definitive diagnosis. | |||
==Biopsy== | ==Biopsy== | ||
Bone marrow biopsy is considered a definitive diagnostic | Bone marrow biopsy is considered a definitive diagnostic method.<ref name=TPLL>{{cite web | title = National Cancer Institute| url =hhttp://seer.cancer.gov/seertools/hemelymph/51f6cf58e3e27c3994bd53f9/ }}</ref> | ||
Revision as of 13:04, 7 October 2015
|
B-cell prolymphocytic leukemia |
|
Differentiating B-cell prolymphocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
B-cell prolymphocytic leukemia biopsy On the Web |
|
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia biopsy |
|
Directions to Hospitals Treating B-cell prolymphocytic leukemia |
|
Risk calculators and risk factors for B-cell prolymphocytic leukemia biopsy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Carlos A Lopez, M.D. [2]
Ovierview
B-cell prolymphocytic leukemia biopsy is considered a definitive diagnosis.
Biopsy
Bone marrow biopsy is considered a definitive diagnostic method.[1]
References
- ↑ [hhttp://seer.cancer.gov/seertools/hemelymph/51f6cf58e3e27c3994bd53f9/ "National Cancer Institute"].